Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Ноя. 15, 2024
Introduction
This
study
presented
an
end-to-end
3D
deep
learning
model
for
the
automatic
segmentation
of
brain
tumors.
Methods
The
MRI
data
used
in
this
were
obtained
from
a
cohort
630
GBM
patients
University
Pennsylvania
Health
System
(UPENN-GBM).
Data
augmentation
techniques
such
as
flip
and
rotations
employed
to
further
increase
sample
size
training
set.
performance
models
was
evaluated
by
recall,
precision,
dice
score,
Lesion
False
Positive
Rate
(LFPR),
Average
Volume
Difference
(AVD)
Symmetric
Surface
Distance
(ASSD).
Results
When
applying
FLAIR,
T1,
ceT1,
T2
modalities,
FusionNet-A
FusionNet-C
best-performing
overall,
with
particularly
excelling
enhancing
tumor
areas,
while
demonstrates
strong
necrotic
core
peritumoral
edema
regions.
excels
areas
across
all
metrics
(0.75
0.83
precision
0.74
scores)
also
performs
well
regions
(0.77
0.77
0.75
scores).
Combinations
including
FLAIR
ceT1
tend
have
better
performance,
especially
Using
only
achieves
recall
0.73
Visualization
results
indicate
that
our
generally
similar
ground
truth.
Discussion
FusionNet
combines
benefits
U-Net
SegNet,
outperforming
both.
Although
effectively
segments
tumors
competitive
accuracy,
we
plan
extend
framework
achieve
even
performance.
Trends in Pharmacological Sciences,
Год журнала:
2024,
Номер
45(11), С. 997 - 1017
Опубликована: Окт. 21, 2024
Central
nervous
system
(CNS)
drug
development
is
plagued
by
high
clinical
failure
rate.
Phenotypic
assays
promote
translation
of
drugs
reducing
complex
brain
diseases
to
measurable,
clinically
valid
phenotypes.
We
critique
recent
platforms
integrating
patient-derived
cells,
which
most
accurately
recapitulate
CNS
disease
phenotypes,
with
higher
throughput
models,
including
immortalized
balance
validity
and
scalability.
These
were
screened
conventional
commercial
chemogenomic
compound
libraries.
explore
emerging
library
curation
strategies
improve
hit
rate
quality,
screening
novel
fragment
libraries
as
alternatives,
for
more
tractable
target
deconvolution.
The
relevant
models
used
in
these
could
harbor
important,
unidentified
targets,
so
we
review
evolving
agnostic
deconvolution
approaches,
chemical
proteomics
artificial
intelligence
(AI),
aid
phenotypic
mechanism
elucidation,
thereby
facilitating
rational
hit-to-drug
optimization.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 12, 2024
Abstract
Brain
tumor
detection
is
crucial
for
early
diagnosis
and
treatment
planning,
as
it
involves
automatically
identifying
localizing
brain
tumors.
However,
existing
methods
often
lack
accuracy
in
detecting
highly
heterogeneous
tumors
struggle
to
balance
speed.
To
alleviate
these
issues,
a
novel
method
termed
channel
shuffling
YOLO
(CS-YOLO)
has
been
proposed,
which
optimizes
both
First,
depthwise
separable
convolution
with
RepVGG
module
designed.
This
combines
efficient
parameter
computation
robust
feature
extraction.
It
extracts
deep
features
from
images,
thereby
enhancing
speed
of
detection.
Second,
enhance
the
network's
performance
perceiving
complex
targets,
convolutional
multi-head
self-attention
constructed.
learns
long-range
dependencies
at
lower
resolutions,
improving
model's
capability
recognize
Finally,
lightweight
designed
used
construct
residual
module.
dramatically
reduces
number
parameters
computational
complexity
model
by
splitting
channels,
thus
learning
generalization
performance.
Experimental
results
demonstrate
that
proposed
surpasses
YOLOv6-L,
YOLOv7,
YOLOv8-L,
latest
RCS-YOLO
terms
on
Br35H
dataset.
Compared
state-of-the-art
methods,
CS-YOLO
significantly
enhances
Specifically,
network
GFLOPs
reduced
41%,
FPS
increased
14%,
AP
improved
0.8%,
achieving
advanced
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Ноя. 15, 2024
Introduction
This
study
presented
an
end-to-end
3D
deep
learning
model
for
the
automatic
segmentation
of
brain
tumors.
Methods
The
MRI
data
used
in
this
were
obtained
from
a
cohort
630
GBM
patients
University
Pennsylvania
Health
System
(UPENN-GBM).
Data
augmentation
techniques
such
as
flip
and
rotations
employed
to
further
increase
sample
size
training
set.
performance
models
was
evaluated
by
recall,
precision,
dice
score,
Lesion
False
Positive
Rate
(LFPR),
Average
Volume
Difference
(AVD)
Symmetric
Surface
Distance
(ASSD).
Results
When
applying
FLAIR,
T1,
ceT1,
T2
modalities,
FusionNet-A
FusionNet-C
best-performing
overall,
with
particularly
excelling
enhancing
tumor
areas,
while
demonstrates
strong
necrotic
core
peritumoral
edema
regions.
excels
areas
across
all
metrics
(0.75
0.83
precision
0.74
scores)
also
performs
well
regions
(0.77
0.77
0.75
scores).
Combinations
including
FLAIR
ceT1
tend
have
better
performance,
especially
Using
only
achieves
recall
0.73
Visualization
results
indicate
that
our
generally
similar
ground
truth.
Discussion
FusionNet
combines
benefits
U-Net
SegNet,
outperforming
both.
Although
effectively
segments
tumors
competitive
accuracy,
we
plan
extend
framework
achieve
even
performance.